Inhibiting key enzymes such as fatty acid synthase (FASN) or acetyl-CoA carboxylase (ACLY) can reduce the energy supply of tumor cells, while potentially increasing immune cell attacks on tumors, providing new strategies for cancer treatment (118, 119). The gene discussed is ACLY; the disease is cancer.